This study, in combination with the work of others [26,27,34,36], identifies ZEB1 as a potential therapeutic target for strategies aimed at improving uptake of therapeutic adenoviruses and preventing or reversing cancer-associated EMT processes while leaving the tumor suppressive functions of TGF-β unaffected. The gene discussed is TGFB1; the disease is cancer.